Literature DB >> 16351358

Asymmetries in global-local processing ability in elderly people with the apolipoprotein e-epsilon4 allele.

Mark W Jacobson1, Dean C Delis, Amy Lansing, Wes Houston, Ryan Olsen, Spencer Wetter, Mark W Bondi, David P Salmon.   

Abstract

Previous studies have identified cognitive asymmetries in elderly people at increased risk for Alzheimer's disease (AD) by comparing standardized neuropsychological tests of verbal and spatial abilities in both preclinical AD and apolipoprotein epsilon4+ elderly groups. This prospective study investigated cognitive asymmetries within a single test by comparing cognitively intact elderly (with and without the epsilon4+ allele) on a learning and memory measure that uses global and local visuospatial stimuli. Both groups demonstrated comparable overall learning and recall. But the epsilon4+ group had a significantly larger discrepancy between their global and local learning scores and had a greater proportion of individuals with more than a one standard deviation difference between their immediate recall of the global and local elements, relative to the epsilon4- group. These findings build on previous studies identifying subgroups of elderly people at greater risk for AD who often demonstrate increased cognitive asymmetries relative to groups without significant risk factors. Copyright (c) 2005 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351358     DOI: 10.1037/0894-4105.19.6.822

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  9 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

Review 3.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

Review 4.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

5.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

6.  Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study.

Authors:  Eric M Fine; Dean C Delis; Spencer R Wetter; Mark W Jacobson; Amy J Jak; Carrie R McDonald; Jodessa C Braga; Leon J Thal; David P Salmon; Mark W Bondi
Journal:  Am J Geriatr Psychiatry       Date:  2008-05       Impact factor: 4.105

7.  Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.

Authors:  Kathleen M Hayden; Maragatha Kuchibhatla; Heather R Romero; Brenda L Plassman; James R Burke; Jeffrey N Browndyke; Kathleen A Welsh-Bohmer
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-27       Impact factor: 4.105

8.  Progressive attenuation of visual global precedence across healthy aging and Alzheimer's disease.

Authors:  Andrea Álvarez-San Millán; Jaime Iglesias; Anahí Gutkin; Ela I Olivares
Journal:  Front Aging Neurosci       Date:  2022-09-20       Impact factor: 5.702

9.  Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.

Authors:  Natalie L Rasgon; Cheri L Geist; Heather A Kenna; Tonita E Wroolie; Katherine E Williams; Daniel H S Silverman
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.